0001127602-22-019045.txt : 20220707 0001127602-22-019045.hdr.sgml : 20220707 20220707164751 ACCESSION NUMBER: 0001127602-22-019045 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220705 FILED AS OF DATE: 20220707 DATE AS OF CHANGE: 20220707 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LeBel Carl CENTRAL INDEX KEY: 0001439275 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39062 FILM NUMBER: 221072111 MAIL ADDRESS: STREET 1: 23256 MARIPOSA DE ORO CITY: MALIBU STATE: CA ZIP: 90265 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Frequency Therapeutics, Inc. CENTRAL INDEX KEY: 0001703647 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472324450 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 HAYDEN AVENUE STREET 2: SUITE 300 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-315-4600 MAIL ADDRESS: STREET 1: 75 HAYDEN AVENUE STREET 2: SUITE 300 CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-07-05 0001703647 Frequency Therapeutics, Inc. FREQ 0001439275 LeBel Carl C/O FREQUENCY THERAPEUTICS, INC. 75 HAYDEN AVE, SUITE 300 LEXINGTON MA 02421 1 Chief Development Officer Common Stock 2022-07-05 4 M 0 15000 A 30764 D Common Stock 2022-07-06 4 S 0 4421 1.52 D 26343 D Restricted Stock Unit 2022-07-05 4 M 0 15000 D Common Stock 15000 0 D Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Includes 4638 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2022. Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units and does not represent discretionary trades by the Reporting Person. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $1.49 to $1.56. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. The restricted stock units will vest as to 50% on February 14, 2022 and 50% on July 4, 2022. /s/ James P. Abely, Attorney-in-Fact for Carl P. LeBel 2022-07-07